File Download

There are no files associated with this item.

Supplementary

Conference Paper: Telbivudine vs Lamivudine in HBeAg-Positive Patients with CHB: Two-Year Efficacy and Predictors of Response

TitleTelbivudine vs Lamivudine in HBeAg-Positive Patients with CHB: Two-Year Efficacy and Predictors of Response
Authors
Issue Date2007
Persistent Identifierhttp://hdl.handle.net/10722/102946

 

DC FieldValueLanguage
dc.contributor.authorLai, CLen_HK
dc.contributor.authorGane, Een_HK
dc.contributor.authorHsu, CWen_HK
dc.contributor.authorChen, YCen_HK
dc.contributor.authorThongsawat, Sen_HK
dc.contributor.authorWang, Yen_HK
dc.contributor.authorChen, Yen_HK
dc.contributor.authorNaoumov, Nen_HK
dc.contributor.authorHan, SHen_HK
dc.contributor.authorHwang, SGen_HK
dc.contributor.authorLim, SGen_HK
dc.contributor.authorBrown, NAen_HK
dc.date.accessioned2010-09-25T20:51:17Z-
dc.date.available2010-09-25T20:51:17Z-
dc.date.issued2007en_HK
dc.identifier.urihttp://hdl.handle.net/10722/102946-
dc.languageengen_HK
dc.relation.ispartofOral Presetnation at the Parallel Oral Session of the HBV Day of the 17th Asian Pacific Association for the Study of the Liver (APASL) Conference on March 28en_HK
dc.titleTelbivudine vs Lamivudine in HBeAg-Positive Patients with CHB: Two-Year Efficacy and Predictors of Responseen_HK
dc.typeConference_Paperen_HK
dc.identifier.emailLai, CL: hrmelcl@hku.hken_HK
dc.identifier.authorityLai, CL=rp00314en_HK
dc.identifier.hkuros133878en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats